Sakura Masuko Selected Research

11,15- dioxo- 9- hydroxy- 2,3,4,5- tetranorprostan- 1,20- dioic acid

1/2021

Development of Monoclonal Antibody-Based EIA for Tetranor-PGDM which Reflects PGD2 Production in the Body.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sakura Masuko Research Topics

Disease

2	Food Hypersensitivity (Food Allergy) 01/2021 - 01/2019
1	Atopic Dermatitis (Atopic Eczema) 12/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021
1	Colitis 01/2018
1	Inflammation (Inflammations) 01/2018

Drug/Important Bio-Agent (IBA)

1	HaptensIBA 12/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	11,15- dioxo- 9- hydroxy- 2,3,4,5- tetranorprostan- 1,20- dioic acidIBA 01/2021
1	ProstaglandinsIBA 01/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2018
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2018
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2018
1	AcidsIBA 01/2018
1	Dextrans (Dextran)FDA Link 01/2018
1	LipidsIBA 01/2018
1	LeukotrienesIBA 01/2018

Therapy/Procedure

1	Oral Administration 01/2018